Party-Drug-Turned-Antidepressant Approaches Approval - Scientific American

Submitted by Anonymous (not verified) on Tue, 10/30/2018 - 07:00

Party-Drug-Turned-Antidepressant Approaches Approval  Scientific AmericanJohnson & Johnson has submitted its esketamine for regulatory approval, but researchers still don't understand how the fast-acting antidepressant lifts moods.